Advertisement

Topics

Companies Related to "Amgen Migraine Drug Gets First Class Medicines" [Most Relevant Company Matches] RSS

06:38 EDT 20th September 2018 | BioPortfolio

Here are the most relevant search results for "Amgen Migraine Drug Gets First Class Medicines" found in our extensive corporate database of over 50,000 company records.

Showing "Amgen Migraine Drug Gets First Class Medicines" Companies 1–25 of 5,100+

Extremely Relevant

Amgen Inc.

Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight agai...


Amgen, Inc.

Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight agai...

Relevant

Amgen Inc

Amgen is a leading human therapeutics company in the biotechnology industry. For 25 years, the company has tapped the power of scientific discovery and innovation to dramatically improve people’s lives.Amgen pioneered the development of novel products based on advances in recombinant DNA and molecular biology and launched the biotechnology industry’s first blockbuster medicines. Today, as a Fo...


Pozen

POZEN is committed to building a portfolio of products with significant commercial potential in select therapeutic areas. Our initial focus is migraine, where we have built a portfolio of four product candidates through a combination of innovation and in-licensing. Migraine is characterized by recurring attacks of headache that are often accompanied by visual, auditory or stomach disturbances. The...

Amgen

The Amgen Foundation (www.amgen.com/citizenship/overview.html) seeks to advance science education; improve patient access to quality care; and strengthen the communities where Amgen staff members live and work. Since 1991, the Foundation has made $140 million in grants to nonprofit organizations throughout the United States, Puerto Rico and Europe that impact society in inspiring and innovative wa...

Amgen AB

Amgen är ett världsledande bioteknologiskt läkemedelsföretag. Genom vetenskapliga upptäckter och innovationer har företaget under 25 års tid bidragit till att radikalt förbättra människors liv. Amgen är föregångare i utvecklingen av nya produkter baserade på rekombinant DNA-teknik och molekylärbiologi och stod för lanseringen av bioteknikindustrins första storsäljande läkemedel....

Healint

Healint helps the one billion people who suffer from migraine and other neurological conditions and is the developer of the world’s largest migraine tracking and research platform Migraine Buddy©. With more than one million registered users and 100 million migraine days tracked on the platform, Migraine Buddy© is the most popular condition-specific app...

Naturewell

Naturewell is engaged in the research and development, distribution and marketing of unique proprietary healthcare products intended for a variety of conditions. Our goal is to offer safe, innovative, technologically-advanced, high-quality and effective products that meet the needs and enhance the lifestyles of our consumers. The Company's primary focus is on the distribution and sale of its migr...

ChemoCentryx, Inc.

ChemoCentryx is a focused pharmaceutical company creating first-in-class, orally available medicines for autoimmune diseases, inflammatory disorders and oncology. By leveraging our pioneering expertise in the field of chemokine research, ChemoCentryx has generated a broad portfolio of medicines targeting the chemokine system, with six product candidates currently in pre-clinical and clinical stage...

Amgen Incorporated

Over the past quarter century, Amgen has pioneered the methods by which human proteins that play a role in disease processes are identified, isolated, produced in quantity and used as therapeutics. Today, Amgenhas research programs in inflammation, metabolic disorders and osteoporosis, neurology, oncology and hematology. The company has R&D facilities in Thousand Oaks, CA; San Francisco, CA; Cambr...

Arrakis Therapeutics

Arrakis Therapeutics is a biopharmaceutical company pioneering the discovery of a new class of medicines that directly target RNA. The company’s TRYST™ and PEARL-seq™ platforms identify new RNA targets and drug candidates to treat diseases unaddressed by today’s medicines. Arrakis is developing a proprietary pipeline of RNA-targeted small ...

Rexahn Pharmaceuticals, Inc.

Rexahn Pharmaceuticals is a clinical stage pharmaceutical company dedicated to developing and commercializing first in class and market leading therapeutics for cancer, CNS disorders, sexual dysfunction and other unmet medical needs. Rexahn currently has three drug candidates in Phase II clinical trials, Archexin®, Serdaxin®, and Zoraxel™ - all ...

Bactevo Ltd.

Bactevo has built a unique, game-changing Totally Integrated Medicines Engine (TIME) to create novel therapeutics. Enabled by advance machine learning, TIME utilises its paradigm shift in the speed, efficiency and quality of drug discovery, as well as dramatically enhanced safety profiling, to improve clinical success. In addition to working with partners ...

VR1, Inc.

VR1 is committed to meeting the needs of patients by providing therapeutic solutions that are effective, safe and accessible. Founded by neurologist and lifelong migraine sufferer Anjan Chatterjee, MD, MPH, MBA, FAAN, FAHS, FAPA, VR1 is a privately held company that focuses on providing treatments to address acute pain associated with migraine and o...

Nanna Therapeutics

Nanna Therapeutics has built a unique, game-changing Totally Integrated Medicines Engine (TIME) to create novel therapeutics. Enabled by advanced machine learning, TIME utilises its paradigm shift in the speed, efficiency and quality of drug discovery, as well as dramatically enhanced safety profiling, to improve clinical success. In addition to working wi...

Magnolia Neurosciences Corporation

Magnolia Neurosciences Corporation is a drug discovery and development company focused on the creation of a novel class of neuroprotective medicines. The company endeavors to make life-changing medicines for the benefit of patients and their families suffering from serious CNS diseases. The company was launched by a $31M Series A investment by Accelerator ...

MedExpressRx

MedExpressRx.com stands as an independent internet drug store which is safe and secure online drug provider with quality assurance and on time delivery of medicines. It is a medicine shop which is present online where customers can buy the drugs that are prescribed to them by the doctor. Our policy is to satisfy every customer visiting our drug store. For us the health of the customers is most imp...

Ascendant Neuro

For the past 15 years, Ascendant Neuro has successfully conducted minimally invasive pain treatment techniques through the innovative use of neurostimulators. Ascendant Neuro's trained physicians, which treat chronic pain of the spine as well as chronic migraine headaches, use neurostimulation to eliminate the symptoms of migraine and chronic head pain.

Oxford BioTherapeutics (OBT)

Oxford BioTherapeutics (OBT) is focused on the development of targeted antibody medicines for oncology. OBT's strategy is to develop innovative antibody-based cancer drugs, with integrated diagnostics, against novel targets that it has discovered in its unique OGAP(R) proteomic database. OBT is in an unrivalled position to convert its novel targets into a successful therapeutic pipeline throug...

Infinity Pharmaceuticals

The mission of Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) is to discover, develop, and deliver to patients best-in-class medicines for the treatment of cancer and related conditions. We have built a pipeline of innovative product candidates for multiple cancer indications, all of which represent proprietary applications of our expertise in small molecule drug technologies. We believe that our s...

endpoint

Endpoint provides clients with high-quality, authoritative advice on the clinical development of medicines. Endpoint's clients include multinational pharmaceutical companies, emerging biomedical ventures, biotechnology investment firms, contract research organizations, regulatory agencies and national health services. Endpoint was started in London by Kenneth Klein, MD, a Harvard-trained physician...

Zogenix, Inc.

Zogenix, Inc., with offices in Emeryville and San Diego, Calif., is a privately held pharmaceutical company focused on the development and commercialization of medicines to treat neuroscience disorders and pain. The company is commercially focused on SUMAVEL(TM) DosePro(TM) (sumatriptan injection) needle-free delivery system, which launched in January 2010, for the acute treatment of migraine and ...

REVOLUTION Medicines, Inc.

The mission of REVOLUTION Medicines is redesigning evolution’s products to treat serious diseases. The company discovers and develops new drugs by reconfiguring natural substances that are inherently rich with biological function as a result of natural selection. The company’s first drug candidates are innovative small molecules that exploit and ...

Ionix Pharmaceuticals

Ionix Pharmaceuticals is Europe’s first biotechnology company dedicated to the discovery of novel analgesic drugs. Ionix focuses on pain associated with chronic debilitating diseases such as osteoarthritis, rheumatoid arthritis, multiple sclerosis and diabetic neuropathy. Develop a world-class IP portfolio in novel drug targets and lead series for analgesic medicines with targeted mode of action...

Moderna, Inc.

Moderna pioneers the discovery and development of messenger RNA (mRNA) therapeutics and vaccines, an entirely new class of medicines that directs the body’s cells to produce intracellular or secreted proteins that can have a therapeutic or preventive benefit for both patients and healthy individuals. With its breakthrough platform, Moderna is creating ...


More From BioPortfolio on "Amgen Migraine Drug Gets First Class Medicines"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks